First report in the world: scientists from China publish the results of clinical trials of TIL therapy technology in advanced liver cancer
September 30, 2021
The clinical trial results of HUST’s autologous tumor infiltrating lymphocytes (TIL) therapy technology in advanced liver cancer were recently published online in the Journal of Clinical Surgery of the Chinese Medical Association, which was the first report of the clinical trial study in the world.Based on the research conducted by Huang Zhiyong’s team from the Department of Hepatobiliary Sur...